Trump's FDA head battered by WSJ for 'torpedoing' a promising cancer treatment

Trump's FDA head battered by WSJ for 'torpedoing' a promising cancer treatment

With the accusation, “Never mind if patients die in the interim,” the editorial board of the conservative Wall Street Journal expressed frustration at how the Food and Drug Administration (FDA) is being run by Commissioner Marty Makary.In a harsh editorial late Wednesday, the editors noted that, under Makary’s watch, approval of drugs has slowed considerably and unreasonably in the past few months as Makary has asserted himself after being appoi…